Prothena Newsroom

Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $62

Futu NewsNov 14 21:35

Prothena Corp Analyst Ratings

BenzingaNov 13 22:41

RBC Capital Maintains Prothena(PRTA.US) With Hold Rating, Maintains Target Price $24

Futu NewsNov 13 20:36

H.C. Wainwright Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $84

Futu NewsNov 13 19:36

JMP Securities Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $83

Futu NewsNov 13 14:32

Prothena's Strategic Advancements and Financial Strength Underpin Buy Rating

TipRanksNov 13 14:00

Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $62

Futu NewsOct 29 20:33

JMP Securities Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $83

Futu NewsOct 28 12:31

H.C. Wainwright Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $84

Futu NewsOct 2 13:32

A Quick Look at Today's Ratings for Prothena(PRTA.US), With a Forecast Between $24 to $84

Futu NewsOct 1 21:02

B of A Securities Maintains Neutral on Prothena Corp, Lowers Price Target to $31

BenzingaOct 1 19:16

HC Wainwright & Co. Reiterates Buy on Prothena Corp, Maintains $84 Price Target

BenzingaOct 1 18:43

Prothena Buy Rating Affirmed: Leadership Changes and Prasinezumab's Promise Signal Investment Opportunity

TipRanksOct 1 18:28

Maintaining Hold on Prothena Amid Executive Changes and Clinical Validation Needs

TipRanksOct 1 16:59

Prothena Corp Analyst Ratings

BenzingaSep 30 20:34

Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $62

Futu NewsSep 30 20:31

Oppenheimer Keeps Their Buy Rating on Prothena (PRTA)

TipRanksSep 30 19:53

Prothena Corp Analyst Ratings

BenzingaAug 14 21:29

Prothena Price Target Cut to $62.00/Share From $66.00 by Oppenheimer

Dow JonesAug 14 21:05

Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Cuts Target Price to $62

Futu NewsAug 14 20:33